Adverse effect of lomotil therapy in shigellosis

JAMA. 1973 Dec 24;226(13):1525-8.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Ampicillin / pharmacology
  • Ampicillin / therapeutic use
  • Atropine / adverse effects*
  • Atropine / therapeutic use
  • Clinical Trials as Topic
  • Colon / microbiology
  • Diarrhea / microbiology
  • Drug Combinations
  • Drug Evaluation
  • Dysentery, Bacillary / drug therapy*
  • Dysentery, Bacillary / microbiology
  • Feces / microbiology
  • Fever / etiology
  • Gastrointestinal Agents / adverse effects*
  • Gastrointestinal Agents / therapeutic use
  • Gastrointestinal Motility / drug effects
  • Humans
  • Intestinal Mucosa / drug effects
  • Intestine, Small / microbiology
  • Isonipecotic Acids / adverse effects*
  • Isonipecotic Acids / therapeutic use
  • Male
  • Oxolinic Acid / pharmacology
  • Oxolinic Acid / therapeutic use
  • Placebos
  • Shigella dysenteriae / isolation & purification
  • Time Factors

Substances

  • Drug Combinations
  • Gastrointestinal Agents
  • Isonipecotic Acids
  • Placebos
  • Atropine
  • Ampicillin
  • Oxolinic Acid